Company Filing History:
1 out of 893 
1 out of 2 Years Active: 2009
Title: The Innovative Mind of Evgeniya Greenbaum: Advancing Cancer Treatment
Introduction
Evgeniya Greenbaum, an accomplished inventor based in Jerusalem, IL, has made significant contributions to the field of medical science with her groundbreaking patent. With a focus on cancer treatment, Greenbaum's innovative work highlights the potential of using viral strains in pharmaceutical compositions to address tumors that resist conventional therapies.
Latest Patents
Greenbaum holds a patent for her invention titled "Compositions of NDV and methods of use thereof for treatment of cancer." This invention reveals methods for inducing tumor regression through the administration of a pharmaceutical composition that includes a lentogenic strain of Newcastle disease virus (NDV). Specifically, the NDV HUJ strain is noted for its efficacy in treating patients who do not respond to traditional anti-cancer treatments.
Career Highlights
Throughout her career, Evgeniya Greenbaum has worked with reputable organizations that emphasize research and development in healthcare. Notable among these is Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where she contributed to innovative projects. Additionally, she was involved with Theravir Management L.P., further solidifying her role in advancing medical technologies.
Collaborations
In her journey, Greenbaum has collaborated with esteemed colleagues such as Zichria Zakay-Rones and Amos Panet. These partnerships have fostered a productive exchange of ideas, ultimately contributing to her successful patent and the advancement of treatment methods in oncology.
Conclusion
Evgeniya Greenbaum's innovative approach to cancer treatment exemplifies the transformative power of inventions in the medical field. Her patent on NDV compositions opens new avenues for patients facing challenges with standard therapies, showcasing the impact of dedicated inventors on healthcare advancements. As her career develops, the medical community may look forward to further contributions from her pioneering spirit.